相关实验视频
Updated: Jan 28, 2026

10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
2.4K
已确定FAM168B为基于T细胞的化学抗原受体癌症治疗的新型候选标
Subrata Pramanik1,2, Manisha Thaker3, Noriko Inoue4
1Jyoti and Bhupat Mehta School of Health Sciences and Technology, Center for Nanotechnology, Indian Institute of Technology Guwahati, Guwahati, 781039, Assam, India. subrata.pramanik@iitg.ac.in.
Discover oncology
|January 27, 2026
概括
研究人员确定FAM168B和FAM168A是潜在的癌症标. 作为一种瘤特异性点,FAM168B显示出有前途的潜力,用于开发针对各种癌症的新型嵌合抗原受体 (CAR) T细胞疗法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 分子生物学分子生物学
背景情况:
- 与衰老相关的疾病,尤其是癌症,需要创新的治疗方法.
- 化学抗原受体 (CAR) T细胞疗法是免疫瘤学的重大进展,工程T细胞向瘤抗原.
- 识别新的癌症特异性点对于提高CAR T细胞治疗疗效至关重要.
研究的目的:
- 在癌细胞上识别新的膜相关蛋白质,以潜在的治疗向.
- 评估FAM168B和FAM168A作为CAR T细胞治疗开发的候选目标.
- 探索FAM168B作为瘤特异抗原的潜力,用于新的癌症免疫疗法.
主要方法:
- 生物信息分析和文献审查以确定候选蛋白质.
- 癌细胞中FAM168B和FAM168A表达模式的表征.
- 评估FAM168B作为CAR T细胞识别目标的潜力.
主要成果:
- 确定FAM168B (序列相似性168成员B的家族) 和FAM168A是癌细胞表面表达的候选膜相关蛋白质.
- FAM168B表现出独特的特征,表明其适合作为瘤特异性点.
- FAM168A (语言癌症抵抗相关蛋白1) 也被确定为一种相关蛋白质.
结论:
- FAM168B是开发CAR T细胞疗法的有前途的新目标.
- 向FAM168B可以扩大CAR T细胞治疗的应用范围,覆盖更广泛的癌症类型.
- 这项研究支持设计更精确和多功能癌症治疗策略.
更多相关视频
相关概念视频
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Diversity of Antigen Receptors
1.5K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.5K
Cancer Therapies
10.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
Antigen Presenting Cells
3.1K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.1K
Internal Receptors
74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Types of Receptors: Cell Surface Receptors
27.2K
Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...
27.2K

